- Diazepam Nasal Spray for Cluster Seizures
Rajesh Shukla PhD, Acorda Therapeutics - Epidiolex (Cannabidiol, CBD)
Kenneth Sommerville MD, GW Pharmaceuticals - Cannabidiol oral solution
Deborah Lee MD PhD, Insys Therapeutics - Carbamazepine IV
Jouko Isojarvi MD PhD, Lundbeck - Ganaxolone
Julia Tsai PhD, Marinus Pharmaceuticals - Development program for status epilepticus
Stephen Kanes MD PhD, Sage Therapeutics - BIS-001, Synthetic Huperzine
Stephen Collins MD PhD, Biscayne Pharmaceuticals - Nasal Diazepam
Mr. Craig Chambliss, Neurelis - ux007, Triheptanoin
Alexandra Bowden PhD, Ultragenyx Pharmaceuticals - Inhaled alprazolam
Jacqueline French MD, on behalf of Alexza Pharmaceuticals - Transdermal CBD gel ZYN002
Donna Gutterman PharmD, Zynerba Pharmaceuticals - ANAVEX 2-73
Christopher Missling PhD, Anavex Life Sciences Corp - ZX008
Gail Farfel PhD, Zogenix
Diazepam Nasal Spray for Cluster Seizures
Rajesh Shukla PhD, Acorda Therapeutics
Epidiolex (Cannabidiol, CBD)
Kenneth Sommerville MD, GW Pharmaceuticals
Cannabidiol oral solution
Deborah Lee MD PhD, Insys Therapeutics
Carbamazepine IV
Jouko Isojarvi MD PhD, Lundbeck
Ganaxolone
Julia Tsai PhD, Marinus Pharmaceuticals
Development program for status epilepticus
Stephen Kanes MD PhD, Sage Therapeutics
BIS-001, Synthetic Huperzine
Stephen Collins MD PhD, Biscayne Pharmaceuticals
Nasal Diazepam
Mr. Craig Chambliss, Neurelis
ux007, Triheptanoin
Alexandra Bowden PhD, Ultragenyx Pharmaceuticals
Inhaled alprazolam
Jacqueline French MD, on behalf of Alexza Pharmaceuticals
Transdermal CBD gel ZYN002
Donna Gutterman PharmD, Zynerba Pharmaceuticals
ANAVEX 2-73
Christopher Missling PhD, Anavex Life Sciences Corp
ZX008
Gail Farfel PhD, Zogenix